Pacira BioSciences, Inc.
PCRX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $3.64M | $3.06M |
| Net Income | -$8.76M | -$6.81M |
| EPS Diluted | -$0.51 | -$11.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR